The Novadial company, the official distributor of solutions for peritoneal dialysis produced by East-Pharm (which is part of the Pharmasyntez Group of Companies), announced the start of regular supplies of Russian solutions to dialysis centers in all regions of Russia. In November 2023, the first batch of 1,500 parcels will arrive in the North-West region.
In the first quarter of 2024, a full line of solutions in volumes of 2000, 2500 and 5000 ml with glucose concentrations of 1.5%, 2.3% and 4.25%, necessary for continuous outpatient and automated peritoneal dialysis procedures, will be supplied to medical institutions in Moscow , St. Petersburg, Northwestern Federal District, Central Federal District, Southern Federal District, Volga Federal District, Siberia and the Far East.
This is the first drug for peritoneal dialysis developed and produced in Russia. Previously, such drugs were supplied only by foreign manufacturers.
